Skip to main content

Table 2 Summary of patient and tumor characteristics for the cohort analyzed

From: Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome

  N %
Gender   
  Female 41 36%
  Male 74 64%
Age at diagnosis (in years)   
  Mean 57.4
  Standard deviation 15.5
  Median 56
  Range 21 – 93
  <40 years 14 12%
  40 to 49 years 24 21%
  50 to 59 years 21 18%
  60 to 69 years 26 23%
  70 to 79 years 24 21%
  80+ years 6 5%
Stage   
  1 33 29%
  2 34 30%
  3 13 11%
  4 35 30%
T-category   
  1 39 34%
  2 45 39%
  3 12 10%
  4 19 17%
N-category   
  0 74 64%
  1 11 10%
  2 30 26%
Smoking history   
  No/Never 33 30%
  Yes 78 70%
  Unknown 4  
Alcohol consumption >20 g/day   
  No/Never/Social 70 63%
  Past or current 41 37%
  Unknown 4  
ECOG performance status   
  0 69 61%
  1 34 30%
  2 7 6%
  3 3 3%
  Unknown 2  
  1. ECOG, Eastern Cooperative Oncology Group; N-category, Node category; T-category, Tumor category.